Essential Innovations Technology (ESIV) 10-K 12 Feb 15 2014 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Oct. 31, 2014	Feb. 09, 2015	Apr. 30, 2014
Document And Entity Information
Entity Registrant Name	ESSENTIAL INNOVATIONS TECHNOLOGY CORP
Entity Central Index Key	1250897
Document Type	10-K
Document Period End Date	31-Oct-14
Amendment Flag	FALSE
Current Fiscal Year End Date	-21
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Public Float			$777,740
Entity Common Stock, Shares Outstanding		24,352,445
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2014

Balance_Sheets

Balance Sheets (USD $)	Oct. 31, 2014	Oct. 31, 2013
Assets
Cash	$134	$82,424
Total current assets	134	82,424
Intellectual property	0	0
Total assets	134	82,424
Liabilities and Stockholders' Deficiency
Accounts payable	399,850	372,872
Accrued expenses	92,500	82,500
Accrued compensation	89,486	10,000
Amounts due to stockholders	74,511	49,570
Current portion of long term debt	491,299	491,299
Total current liabilities	1,147,646	1,006,241
Stockholders' Deficiency
Preferred stock: $0.001 par value, authorized 10,000,000 shares, issued and outstanding nil shares (2013 - nil)	0	0
Common stock: $0.001 par value, authorized 500,000,000 shares, issued and outstanding 24,352,445 shares (2013 - 23,452,445)	24,353	23,453
Additional paid-in capital	3,208,540	3,186,940
Accumulated deficit	-1,849,309	-1,849,309
Deficit accumulated during development stage	-2,531,096	-2,284,901
Total stockholders' deficiency	-1,147,512	-923,817
Total liabilities and stockholders' deficiency	$134	$82,424

Balance_Sheets_Parenthetical

Balance Sheets (Parenthetical) (USD $)	Oct. 31, 2014	Oct. 31, 2013
Stockholders equity:
Preferred stock, par value	$0.00	$0.00
Preferred stock, authorized shares	10,000,000	10,000,000
Preferred stock, issued shares	0	0
Preferred stock, outstanding shares	0	0
Common stock, par value	$0.00	$0.00
Common stock, authorized shares	500,000,000	500,000,000
Common stock, issued shares	24,352,445	23,452,445
Common stock, outstanding shares	24,352,445	23,452,445

Statements_of_Operations

Statements of Operations (USD $)	12 Months Ended		60 Months Ended
	Oct. 31, 2014	Oct. 31, 2013	Oct. 31, 2014
Income Statement [Abstract]
Revenue	$0	$0	$0
Expenses:
General and administrative	220,863	276,486	964,372
Marketing	0	239,838	1,280,838
Impairment loss	0	260,068	260,068
Total operating expenses	220,863	776,392	2,505,278
Loss from operations	-220,863	-776,392	-2,505,278
Interest expense	-25,332	-25,413	-128,111
Gain on debt forgiveness	0	0	102,293
Net Loss	($246,195)	($801,805)	($2,531,096)
Net loss per share
Basic and diluted net loss per share	($0.01)	($0.04)
Weighted average number of shares outstanding
Basic and diluted	23,829,705	17,960,000

Statements_of_Stockholders_Equ

Statements of Stockholders' Equity (Deficiency) and Comprehensive Loss (USD $)	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Deficit Accumulated during Development Stage	Total
Beginning Balance, Amount at Oct. 31, 2011	$11,622	$1,218,588	($1,849,309)	($356,328)	($975,427)
Beginning Balance, Shares at Oct. 31, 2011	11,622,560
Net loss				-1,126,768	-1,126,768
Common stock issued for services received, Shares	4,227,500
Common stock issued for services received, Amount	4,228	1,044,272			1,048,500
Issuances of common stock for intellectual property acquired, Shares	1,000,000
Issuances of common stock for intellectual property acquired, Amount	1,000	199,000			200,000
Issuances of options for intellectual property acquired		60,068			60,068
Common stock issued for services received from related parties, Shares	150,000
Common stock issued for services received from related parties, Amount	150	29,850			30,000
Common stock issued for funds received, Shares	244,885
Common stock issued for funds received, Amount	245	48,732			48,977
Common stock issued for settlement of amounts owing, Shares	87,500
Common stock issued for settlement of amounts owing, Amount	88	17,412			17,500
Ending Balance, Amount at Oct. 31, 2012	17,333	2,617,922	-1,849,309	-1,483,096	-697,150
Ending Balance, Shares at Oct. 31, 2012	17,332,445
Net loss				-801,805	-801,805
Common stock issued for accrued remuneration, Shares	1,000,000
Common stock issued for accrued remuneration, Amount	1,000	199,000			200,000
Common stock issued for services received, Shares	1,070,000
Common stock issued for services received, Amount	1,070	221,730			222,800
Common stock issued for funds received, Shares	4,050,000
Common stock issued for funds received, Amount	4,050	108,450			112,500
Options issued for services received		39,838			39,838
Ending Balance, Amount at Oct. 31, 2013	23,453	3,186,940	-1,849,309	-2,284,901	-923,817
Ending Balance, Shares at Oct. 31, 2013	23,452,445
Net loss				-246,195	-246,195
Common stock issued for funds received, Shares	900,000
Common stock issued for funds received, Amount	900	21,600			22,500
Ending Balance, Amount at Oct. 31, 2014	$24,353	$3,208,540	($1,849,309)	($2,531,096)	($1,147,512)
Ending Balance, Shares at Oct. 31, 2014	24,352,445

Statements_of_Cash_Flows

Statements of Cash Flows (USD $)	12 Months Ended		60 Months Ended
	Oct. 31, 2014	Oct. 31, 2013	Oct. 31, 2014
Cash flows from operating activities:
Net loss	($246,195)	($801,805)	($2,531,096)
Impairment loss	0	260,068	260,068
Adjustments to reconcile net loss for the period to net cash used in operating activities:
Common stock issued to related parties for services received	0	0	150,000
Common stock issued for services received	0	222,800	1,355,300
Options issued for services received	0	39,838	39,838
Gain on forgiveness of debt	0	0	-102,293
Changes in assets and liabilities:
Accounts payable	26,978	26,952	40,320
Accrued expenses	10,000	60,000	152,500
Accrued compensation	79,486	115,787	369,273
Net cash used in operating activities	-129,731	-76,360	-266,090
Cash provided by financing activities:
Proceeds received for common stock	22,500	112,500	170,000
Advances from stockholders, net	24,941	46,138	96,224
Net cash provided by financing activities	47,441	158,638	266,224
Increase in cash during the period	-82,290	82,278	134
Cash at beginning of the period	82,424	146	0
Cash at end of the period	$134	$82,424	$134

1_Description_of_Business_and_

1. Description of Business and Summary of Significant Accounting Policies	12 Months Ended
	Oct. 31, 2014
Accounting Policies [Abstract]
Description of Business and Summary of Significant Accounting Policies	Organization
	The Company has secured exclusive distribution rights to represent equipment manufactured by one of China’s top HVAC (heating, ventilation and air conditioning) manufacturers, Mammoth China, for the countries of the Philippines and the United Arab Emirates. Such products and technologies represented include geothermal and water source heat pumps, commercial roof top units, fan coils and variable air volume systems. In addition, the Company is endeavouring to facilitate the establishment of an internationally recognized industry association (IGHSPA – the International Ground Source Heat Pump Association) in both of these countries to enhance certain product reputation and credibility.
	Development Stage
	The Company is devoting substantially all of its efforts on establishing the business and principal operations have not commenced. All losses accumulated since inception of the development stage have been considered as part of the Company’s development stage activities.
	The Company re- entered the development stage effective November 1, 2009.
	Going Concern
	The Company’s financial statements have been prepared in conformity with accounting principles generally accepted in the United States applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has not generated any revenue since commencement of the development stage, has an accumulated deficit, and has had no positive cash flows from operations. It is the Company’s intention to raise additional equity to finance development of a market for its products until positive cash flows can be generated from its operations. However, there can be no assurance that such additional funds will be available to the Company when required or on terms acceptable to the Company. Such limitations could have a material adverse effect on the Company’s business, financial condition or operations, and these financial statements do not include any adjustment that could result. Failure to obtain sufficient additional funding would necessitate the Company to reduce or limit its operating activities or even discontinue operations.
	Basis of presentation
	These financial statements have been prepared in accordance accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”).
	Intangible Assets
	Intangible assets consist of intellectual property. Intangible assets with definite lives or bases for productivity are recorded at cost and are amortized over the expected life or productivity base of the asset. Intangible assets with indefinite lives are not amortized but are evaluated periodically for impairment. Management tests intangible assets for impairment at least annually or more frequently whenever events or changes in circumstances indicate that the carrying value may not be recoverable. During the year ended October 31, 2013 the Company determined that there was an impairment of intangible assets in the amount of $260,068.
	Advertising Expenses
	Advertising costs are expensed as incurred. The Company did not incur any advertising costs during the years ended October 31, 2014 and 2013.
	Income Taxes
	Deferred income tax assets and liabilities are determined based on temporary differences between financial reporting and tax bases of assets and liabilities, operating loss, and tax credit carryforwards, and are measured using the enacted income tax rates and laws that will be in effect when the differences are expected to be recovered or settled.  Realization of certain deferred income tax assets is dependent upon generating sufficient taxable income in the appropriate jurisdiction.  The Company records a valuation allowance to reduce deferred income tax assets to amounts that are more likely than not to be realized.  The initial recording and any subsequent changes to valuation allowances are based on a number of factors (positive and negative evidence).  The Company considers its actual historical results to have a stronger weight than other, more subjective, indicators when considering whether to establish or reduce a valuation allowance.
	The Company continually evaluates its uncertain income tax positions and may record a liability for any unrecognized tax benefits resulting from uncertain income tax positions taken or expected to be taken in an income tax return.  Estimated interest and penalties are recorded as a component of interest expense and other expense, respectively.
	Because tax laws are complex and subject to different interpretations, significant judgment is required.  As a result, the Company makes certain estimates and assumptions in: (1) calculating its income tax expense, deferred tax assets, and deferred tax liabilities; (2) determining any valuation allowance recorded against deferred tax assets; and (3) evaluating the amount of unrecognized tax benefits, as well as the interest and penalties related to such uncertain tax positions.  The Company’s estimates and assumptions may differ significantly from tax benefits ultimately realized.
	Net Loss Per Share
	Basic net loss per share is calculated by dividing the net loss attributable to common shareholders by the weighted average number of common shares outstanding in the period. Diluted loss per share takes into consideration common shares outstanding (computed under basic loss per share) and potentially dilutive securities. For the years ended October 31, 2014 and 2013, outstanding stock options and warrants are antidilutive because of net losses, and as such, their effect has not been included in the calculation of diluted net loss per share. Common shares issuable are considered outstanding as of the original approval date for purposes of earnings per share computations.
	Comprehensive Income (Loss)
	The Company has no components of other comprehensive income (loss) and accordingly, no statement of comprehensive income (loss) is included in the accompanying financial statements.
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the fiscal year. The Company bases its estimates on historical experience, current conditions and on other assumptions that it believes to be reasonable under the circumstances. Actual results could differ from those estimates and assumptions.
	Financial Instruments
	The Company has the following financial instruments: cash, accounts payable, accrued expenses and compensation,  and amounts due to stockholders. The carrying value of these financial instruments approximates their fair value due to their liquidity or their short-term nature.
	Share-Based Compensation
	The Company accounts for stock-based awards at fair value on date of grant and recognition of compensation over the service period for awards expected to vest.  The fair value of stock options is determined using the Black-Scholes valuation model, which is consistent with the Company’s valuation techniques previously utilized for options in footnote disclosures.
	Recent Accounting Pronouncements
	The Company reviews recently adopted and proposed accounting standards on a continual basis. For the years ended October 31, 2014 and 2013 no new pronouncements had a material impact on the Company’s financial statements.

2_Intellectual_Property

2. Intellectual Property	12 Months Ended
	Oct. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]
Intellectual Property	During the year ended October 31, 2012 the Company acquired worldwide marketing rights to heating and cooling technology from a company controlled by the father of the sole officer and director of the Company (grantor) for 1,000,000 shares of common stock of the Company with a fair value of $200,000 and options to purchase 500,000 shares of common stock, until January 15, 2017, at an exercise price of $0.25 per share.
	The Company also agreed to pay, for an indefinite term, to the grantor a royalty of 3% of gross proceeds earned from sale or use of the technology. Additionally, the Company agreed to pay, over the next two years and on a best efforts basis, to the grantor up to $500,000 for the grantor to use for prototyping and commercialization for the technology. No payments have been made to date.
	During the year ended October 31, 2013 the Company determined that the carrying value of the Intellectual Property exceeded the fair value and has recorded an impairment loss of $260,068.

3_Term_Loan

3. Term Loan	12 Months Ended
	Oct. 31, 2014
Debt Disclosure [Abstract]
Term Loan	The foreclosure of the Company’s operations and assets relating to the business of manufacture, sales and installation of geo exchange heat products and technology on March 27, 2009 were in satisfaction of $2,413,070 owing to a secured lender. The Company still owes $491,299 to a secured lender.  By agreement, the secured lender has agreed that there will be no further interest, penalties or fees charged and that the Company has until October 31, 2015 to negotiate a settlement of this debt with the secured lender. The debt is secured by a charge over all the assets of the Company.

4_RelatedParty_Transactions_an

4. Related-Party Transactions and Balances	12 Months Ended
	Oct. 31, 2014
Related Party Transactions [Abstract]
Related-Party Transactions and Balances	During the years ended October 31, 2014 and 2013 stockholders of the Company advanced $72,204 and $46,138, respectively and were repaid $41,836 and $nil, respectively. The balance owing as at October 31, 2014 of $74,511, is included in advances due to stockholders.
	An entity, related by common ownership to two shareholders of the Company, has provided consulting services in the amount of $30,000 and $45,000 during the respective years ended October 31, 2014 and 2013. The balance owing as at October 31, 2014 of $92,500 is included in accrued expenses.
	Accrued Remuneration and Services
	During the years ended October 31, 2014 and 2013 the Company’s president and sole director provided management services for which the amounts of $120,000 and $120,000 respectively have been accrued. During the years ended October 31, 2014 and 2013 $nil and $200,000, respectively, of the accrual was settled through the respective issuance of nil and 1,000,000 shares of common stock. The balance owing as at October 31, 2014 of $94,033 is included in accrued compensation.

5_Share_Capital

5. Share Capital	12 Months Ended
	Oct. 31, 2014
Equity [Abstract]
Share Capital	Preferred Stock
	The Company’s authorized capital includes 10,000,000 shares of preferred stock of $0.001 par value. The designation of rights including voting powers, preferences, and restrictions shall be determined by the Board of Directors before the issuance of any shares.
	No shares of preferred stock are issued and outstanding as of October 31, 2014 and 2013.
	Common Stock
	The Company is authorized to issue 500,000,000 shares of common stock, par value of $0.001.
	During the year ended October 31, 2014 the Company
	●	Issued 900,000 shares of common stock for cash proceeds of $22,500
	During the year ended October 31, 2013, the Company issued:
	●	70,000 shares of common stock for services with a fair value of $62,800.
	●	1,000,000 shares of common stock as settlement of $200,000 of accrued remuneration.
	●	450,000 shares  of common stock for cash proceeds of $22,500.
	●	1,000,000 shares of common stock for services received with a fair value of $160,000
	●	3,600,000 shares of common stock for cash proceeds of $90,000
	Stock Purchase Warrants
	At October 31, 2014, the Company had reserved shares of common stock for the following outstanding warrants to purchase 66,494 shares of the Company’s common stock:
	Number of warrants	Exercise Price	Expiry
	66,494	$0.02	2050
	No warrants were issued in 2014 or 2013.

6_StockBased_Compensation

6. Stock-Based Compensation	12 Months Ended
	Oct. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock-Based Compensation	Although the Company does not have a formal stock option plan, it issues stock options to directors, employees, advisors and consultants. Stock options generally have a four- to five-year contractual term, vest immediately and have no forfeiture provisions. The fair value of each option granted is estimated at the date of grant using the Black-Scholes option pricing model.
	A summary of the Company’s stock options as of October 31, 2014 is as follows:
			Number of Options				Weighted Average Exercise Price
	Outstanding at October 31, 2013			550,000				0.3
	Options issued			-				-
	Outstanding at October 31, 2014			550,000			$	0.3
	The following table summarizes stock options outstanding at October 31, 2014:
	Exercise Price				Number Outstanding at October 31, 2014				Average Remaining Contractual Life (Years)		Number
											Exercisable at
											31-Oct-14		Intrinsic value
	$	0.25				500,000				2.25		500,000		-
	$	0.75				50,000				0.5		50,000		-
	As at October 31, 2014 550,000 shares of common stock were reserved for outstanding options. The Company’s policy is to issue new shares as settlement of options exercised. There were no options issued and none exercised during the year ended October 31, 2014. The fair value of each option granted is estimated at the date of grant using the Black-Scholes option-pricing model The assumptions used in calculating the fair value of the options granted were: risk-free interest rate of 1.0%, a 2 year expected life, a dividend yield of 0.0%, and a stock price volatility factor of 100%.

7_Income_Taxes

7. Income Taxes	12 Months Ended
	Oct. 31, 2014
Income Tax Disclosure [Abstract]
Income Taxes	No provision for income taxes has been made for the period since the Company incurred net losses.
	Deferred Tax Assets
	As of October 31, 2014, the Company has net operating losses of approximately $12,900,000 available for future deduction from taxable income derived in the United States which begin to expire in the year 2022. The potential benefit of net operating loss carryforwards has not been recognized in the consolidated financial statements since the Company cannot determine that it is more likely than not that such benefit will be utilized in future years. The components of the net deferred tax asset and the amount of the valuation allowance are as follows:
		2014			2013
	Deferred tax assets:
	Net operating loss carryforwards (expiring through 2031)	$	4,377,000		$	4,293,000
	Valuation allowance		(4,377,000	)		(4,293,000	)
	Net deferred tax assets	$	--		$	--
	The change in the valuation allowance was an increase of $84,000 for the year ended October 31, 2014 and an increase of $137,000 for the year ended October 31, 2013. The utilization of the tax net operating loss carry forwards may be limited due to ownership changes. The Company’s tax returns are open to examination for the years ended October 31, 2008 to 2014.
	The difference between the benefit for income taxes and income taxes computed using the US federal income tax rate are as follows:
		2014			2013
	Benefit computed using statutory rate (34%)	$	(84,000	)	$	(137,000	)
	Change in valuation allowance		84,000			137,000
	Net deferred tax assets	$	--		$	--

8_Commitments_and_Contingencie

8. Commitments and Contingencies	12 Months Ended
	Oct. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Litigation
	On November 14, 2007, the defendants in a lawsuit filed by a former subsidiary of the Company filed a counterclaim against the Company and several of its officers, alleging breach of contract, wrongful dismissal, defamation, abuse of process, and other claims. The Company believes that the counterclaims are without merit and intends to defend them vigorously as it continues to press its claims that the individual defendants breached their noncompetition agreements with the Company and its former subsidiary as well as their fiduciary obligations. The Company’s management has determined that no provision for loss is necessary as of October 31, 2014.

1_Description_of_Business_and_1

1. Description of Business and Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Oct. 31, 2014
Accounting Policies [Abstract]
Development Stage	The Company is devoting substantially all of its efforts on establishing the business and principal operations have not commenced. All losses accumulated since inception of the development stage have been considered as part of the Company’s development stage activities.
	The Company re- entered the development stage effective November 1, 2009.
Going Concern	The Company’s financial statements have been prepared in conformity with accounting principles generally accepted in the United States applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has not generated any revenue since commencement of the development stage, has an accumulated deficit, and has had no positive cash flows from operations. It is the Company’s intention to raise additional equity to finance development of a market for its products until positive cash flows can be generated from its operations. However, there can be no assurance that such additional funds will be available to the Company when required or on terms acceptable to the Company. Such limitations could have a material adverse effect on the Company’s business, financial condition or operations, and these financial statements do not include any adjustment that could result. Failure to obtain sufficient additional funding would necessitate the Company to reduce or limit its operating activities or even discontinue operations.
Basis of presentation	These financial statements have been prepared in accordance accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”).
Intangible Assets	Intangible assets consist of intellectual property. Intangible assets with definite lives or bases for productivity are recorded at cost and are amortized over the expected life or productivity base of the asset. Intangible assets with indefinite lives are not amortized but are evaluated periodically for impairment. Management tests intangible assets for impairment at least annually or more frequently whenever events or changes in circumstances indicate that the carrying value may not be recoverable. During the year ended October 31, 2013 the Company determined that there was an impairment of intangible assets in the amount of $260,068.
Advertising Expenses	Advertising costs are expensed as incurred. The Company did not incur any advertising costs during the years ended October 31, 2014 and 2013.
Income Taxes	Deferred income tax assets and liabilities are determined based on temporary differences between financial reporting and tax bases of assets and liabilities, operating loss, and tax credit carryforwards, and are measured using the enacted income tax rates and laws that will be in effect when the differences are expected to be recovered or settled.  Realization of certain deferred income tax assets is dependent upon generating sufficient taxable income in the appropriate jurisdiction.  The Company records a valuation allowance to reduce deferred income tax assets to amounts that are more likely than not to be realized.  The initial recording and any subsequent changes to valuation allowances are based on a number of factors (positive and negative evidence).  The Company considers its actual historical results to have a stronger weight than other, more subjective, indicators when considering whether to establish or reduce a valuation allowance.
	The Company continually evaluates its uncertain income tax positions and may record a liability for any unrecognized tax benefits resulting from uncertain income tax positions taken or expected to be taken in an income tax return.  Estimated interest and penalties are recorded as a component of interest expense and other expense, respectively.
	Because tax laws are complex and subject to different interpretations, significant judgment is required.  As a result, the Company makes certain estimates and assumptions in: (1) calculating its income tax expense, deferred tax assets, and deferred tax liabilities; (2) determining any valuation allowance recorded against deferred tax assets; and (3) evaluating the amount of unrecognized tax benefits, as well as the interest and penalties related to such uncertain tax positions.  The Company’s estimates and assumptions may differ significantly from tax benefits ultimately realized.
Net Loss per Share	Basic net loss per share is calculated by dividing the net loss attributable to common shareholders by the weighted average number of common shares outstanding in the period. Diluted loss per share takes into consideration common shares outstanding (computed under basic loss per share) and potentially dilutive securities. For the years ended October 31, 2014 and 2013, outstanding stock options and warrants are antidilutive because of net losses, and as such, their effect has not been included in the calculation of diluted net loss per share. Common shares issuable are considered outstanding as of the original approval date for purposes of earnings per share computations.
Comprehensive Income (Loss)	The Company has no components of other comprehensive income (loss) and accordingly, no statement of comprehensive income (loss) is included in the accompanying financial statements.
Use of Estimates	The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the fiscal year. The Company bases its estimates on historical experience, current conditions and on other assumptions that it believes to be reasonable under the circumstances. Actual results could differ from those estimates and assumptions.
Financial Instruments	The Company has the following financial instruments: cash, accounts payable, accrued expenses and compensation,  and amounts due to stockholders. The carrying value of these financial instruments approximates their fair value due to their liquidity or their short-term nature.
Share-Based Compensation	The Company accounts for stock-based awards at fair value on date of grant and recognition of compensation over the service period for awards expected to vest.  The fair value of stock options is determined using the Black-Scholes valuation model, which is consistent with the Company’s valuation techniques previously utilized for options in footnote disclosures.
Recent Accounting Pronouncements	The Company reviews recently adopted and proposed accounting standards on a continual basis. For the years ended October 31, 2014 and 2013 no new pronouncements had a material impact on the Company’s financial statements.

5_Share_Capital_Tables

5. Share Capital (Tables)	12 Months Ended
	Oct. 31, 2014
Equity [Abstract]
Stock Purchase Warrants	Number of warrants	Exercise Price	Expiry
	66,494	$0.02	2050

6_StockBased_Compensation_Tabl

6. Stock-Based Compensation (Tables)	12 Months Ended
	Oct. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Company's stock options			Number of Options				Weighted Average Exercise Price
	Outstanding at October 31, 2013			550,000				0.3
	Options issued			-				-
	Outstanding at October 31, 2014			550,000			$	0.3
Summary of stock options outstanding	Exercise Price				Number Outstanding at October 31, 2014				Average Remaining Contractual Life (Years)		Number
											Exercisable at
											31-Oct-14		Intrinsic value
	$	0.25				500,000				2.25		500,000		-
	$	0.75				50,000				0.5		50,000		-

7_Income_Taxes_Tables

7. Income Taxes (Tables)	12 Months Ended
	Oct. 31, 2014
Income Tax Disclosure [Abstract]
Deferred tax asset		2014			2013
	Deferred tax assets:
	Net operating loss carryforwards (expiring through 2031)	$	4,377,000		$	4,293,000
	Valuation allowance		(4,377,000	)		(4,293,000	)
	Net deferred tax assets	$	--		$	--
Income tax reconcilliation		2014			2013
	Benefit computed using statutory rate (34%)	$	(84,000	)	$	(137,000	)
	Change in valuation allowance		84,000			137,000
	Net deferred tax assets	$	--		$	--

4_RelatedParty_Transactions_an1

4. Related-Party Transactions and Balances (Details Narrative) (USD $)	12 Months Ended		60 Months Ended
	Oct. 31, 2014	Oct. 31, 2013	Oct. 31, 2014
Related-Party Transactions And Balances Details Narrative
Advances from stockholders	$24,941	$46,138	$96,224
Advances from stockholders repaid	41,836	0
Amounts due to stockholders	$74,511	$49,570	$74,511

5_Share_Capital_Stock_Purchase

5. Share Capital - Stock Purchase Warrants (Details) (Warrants, USD $)	12 Months Ended
	Oct. 31, 2014
Warrants
Number of Shares Outstanding, ending	66,494
Weighted Average Exercise Price Outstanding, ending	$0.02
Expiry	1-Jan-50

6_StockBased_Compensation_Opti

6. Stock-Based Compensation - Option activity (Details) (Stock Options, USD $)	12 Months Ended
	Oct. 31, 2014
Stock Options
Number of Options
Number of Shares Outstanding, beginning	550,000
Number of Options Issued	0
Number of Shares Outstanding, ending	550,000
Weighted Average Exercise Price
Weighted Average Exercise Price Outstanding, beginning	$0.30
Weighted Average Exercise Price Issued	$0
Weighted Average Exercise Price Outstanding, ending	$0.30

6_StockBased_Compensation_Opti1

6. Stock-Based Compensation - Options outstanding (Details 1) (USD $)	12 Months Ended
	Oct. 31, 2014
Option Price 1
Weighted Average Exercise Price Outstanding, ending	$0.25
Number of Shares Outstanding, ending	500,000
Weighted Average Remaining Contractual Life (in years) Outstanding	2 years 3 months
Number of Options Exercisable	500,000
Intrinsic value	$0
Option Price 2
Weighted Average Exercise Price Outstanding, ending	$0.75
Number of Shares Outstanding, ending	50,000
Weighted Average Remaining Contractual Life (in years) Outstanding	6 months
Number of Options Exercisable	50,000
Intrinsic value	$0

7_Income_Taxes_Details

7. Income Taxes (Details) (USD $)	Oct. 31, 2014	Oct. 31, 2013
Deferred tax assets:
Net operating loss carryforwards (expiring through 2031)	$4,377,000	$4,293,000
Valuation allowance	-4,377,000	-4,293,000
Net deferred tax assets	$0	$0

7_Income_Taxes_Details_1

7. Income Taxes (Details 1) (USD $)	12 Months Ended
	Oct. 31, 2014	Oct. 31, 2013
Income Taxes Details 1
Benefit computed using statutory rate (34%)	($84,000)	($137,000)
Change in valuation allowance	84,000	137,000
Net deferred tax assets	$0	$0